News | RIVM

Care workers in nursing homes and small-scale residential facilities invited for COVID-19 vaccination starting today

As of today, the ca. 269,000 care workers of nursing homes and small-scale residential facilities in the Netherlands are invited to make an appointment for a COVID-19 vaccination.

The spread of the UK coronavirus variant in the Netherlands

The UK variant of the coronavirus (SARS-CoV-2) has been found in 11 people in the Netherlands so far: 5 people in the Amsterdam region, 5 people in the Rotterdam region and 1 person in the Nijmegen

Improvement of air quality continues

In 2019, the calculated concentrations of nitrogen dioxide (NO2) and particulate matter (PM10) were below the European limit values in almost the whole of the Netherlands. Locally, the limit value for nitrogen dioxide is still being exceeded.

RIVM international circular economy knowledge partner

As of 7 December 2020, RIVM has become a knowledge partner of the international Platform for Accelerating the Circular Economy (PACE).

First COVID-19 vaccination in the Netherlands on 8 January 2021

If the European Medicines Agency (EMA) approves BioNTech/Pfizer’s COVID-19 vaccine next week, the first people in the Netherlands will receive the COVID-19 vaccine on Friday 8 January 2021.

First wave of COVID-19 had major impact on regular healthcare and health

During the first wave, the novel coronavirus (SARS-CoV-2) had a major impact on healthcare in the Netherlands. Many patients faced delays in appointments and treatments.

Possible start of COVID-19 vaccination in early January

If all goes well, the first people in the Netherlands will be vaccinated against COVID-19 in early January. The logistics operation aims to start vaccination in the week of 4 January 2021.

Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion

Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

New data on antimicrobial resistance in Europe

New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw